Patents by Inventor Manuela Duerr

Manuela Duerr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
    Publication number: 20240166763
    Abstract: The disclosure provides methods and compositions for treating tumors, particularly HER2-positive tumors. The method comprises administering a therapeutically effective amount of a HER2/4-1BB bispecific fusion protein. The HER2/4-1BB bispecific fusion protein is administered at a dose of from about 2.5 mg/kg to about 27 mg/kg, once every week, once every two weeks, or once every three week.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 23, 2024
    Inventors: Shane OLWILL, Louis MATIS, Ingmar BRUNS, Manuela DUERR, Rushdia Zareen YUSUF, Markus ZETTL, Andrea ALLERSDORFER, Aizea Morales KASTRESANA, Corinna SCHLOSSER
  • Treatment For M Treatment For Multiple Sclerosis
    Publication number: 20120116059
    Abstract: The present invention relates to methods for the treatment and/or prophylaxis of multiple sclerosis (MS). Antagonists of GM-CSF, such as antibodies specific for GM-CSF or the GM-CSF receptor, are effective in the treatment and/or prophylaxis of multiple sclerosis.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 10, 2012
    Applicant: MORPHOSYS AG
    Inventors: Stefan Steidl, Manuela Duerr, Elisabeth Thomassen-Wolf, Matthew Downham, Robert Friesen